The effective preparation of two new pyrimidine- and pyridine-based organic crystalline salts with substituted acidic moieties (i.e., (Z)-4-(naphthalen-2-ylamino)-4-oxobut-2-enoic acid (DCNO) and 2-hydroxy-3,5-dinitrobenzoic acid (PCNP)) using methanol as a solvent has been reported. These molecular salts have ionic interactions that are responsible for their structural stabilization in their solid-state assemblies. The crystal structures of DCNO and PCNP were determined by the single-crystal X-ray diffraction (SCXRD) technique. The SCXRD study inferred that cations and anions are strongly packed due to N–H···O, N–H···N, and C–H···O noncovalent interactions in DCNO, whereas in PCNP, N–H···N noncovalent interactions are absent. The noncovale...
Examination of the crystal structures of (Me<sub>4</sub>N)(dcnm) (<b>1</b>), (Me<sub>4</sub>N)(dcn...
Single crystal X-ray structure determinations have previously been described for picrate salts of a ...
Two mixed crystals were obtained by crystallizing the active pharmaceutical ingredient pyridoxine [s...
The effective preparation of two new pyrimidine- and pyridine-based organic crystalline salts with s...
The effective preparation of two new pyrimidine- and pyridine-based organic crystalline salts with s...
Four co-crystals involving dicarboxylic acids and pyridine derivatives, viz. (ox)0.5(2-CNpy) (1), (a...
Seven crystal structures of pyromellitic acid or trimesic acid salts of molecules that contain pyrid...
All prepared compounds were fully characterized via FT- IR spectroscopic technique and elemental ana...
Organic salt, 9-aminoacridinium picrate (9-AAcPc), containing equimolar quantities of 9-aminoacridin...
The optical charge-transfer (CT) property and the crystal structure of (Z)-4-(1-cyano-2-(2,4,5-trime...
2-Chloro-4-nitrobenzoic acid (2c4n) is an antiviral agent used for the treatment of HIV infection an...
The opening section of this thesis reviews the application of the concepts of supramolecular chemist...
R factor = 0.066; wR factor = 0.141; data-to-parameter ratio = 16.9. In the crystal structure of the...
Examination of the crystal structures of (Me<sub>4</sub>N)(dcnm) (<b>1</b>), (Me<sub>4</sub>N)(dcn...
Examination of the crystal structures of (Me<sub>4</sub>N)(dcnm) (<b>1</b>), (Me<sub>4</sub>N)(dcn...
Examination of the crystal structures of (Me<sub>4</sub>N)(dcnm) (<b>1</b>), (Me<sub>4</sub>N)(dcn...
Single crystal X-ray structure determinations have previously been described for picrate salts of a ...
Two mixed crystals were obtained by crystallizing the active pharmaceutical ingredient pyridoxine [s...
The effective preparation of two new pyrimidine- and pyridine-based organic crystalline salts with s...
The effective preparation of two new pyrimidine- and pyridine-based organic crystalline salts with s...
Four co-crystals involving dicarboxylic acids and pyridine derivatives, viz. (ox)0.5(2-CNpy) (1), (a...
Seven crystal structures of pyromellitic acid or trimesic acid salts of molecules that contain pyrid...
All prepared compounds were fully characterized via FT- IR spectroscopic technique and elemental ana...
Organic salt, 9-aminoacridinium picrate (9-AAcPc), containing equimolar quantities of 9-aminoacridin...
The optical charge-transfer (CT) property and the crystal structure of (Z)-4-(1-cyano-2-(2,4,5-trime...
2-Chloro-4-nitrobenzoic acid (2c4n) is an antiviral agent used for the treatment of HIV infection an...
The opening section of this thesis reviews the application of the concepts of supramolecular chemist...
R factor = 0.066; wR factor = 0.141; data-to-parameter ratio = 16.9. In the crystal structure of the...
Examination of the crystal structures of (Me<sub>4</sub>N)(dcnm) (<b>1</b>), (Me<sub>4</sub>N)(dcn...
Examination of the crystal structures of (Me<sub>4</sub>N)(dcnm) (<b>1</b>), (Me<sub>4</sub>N)(dcn...
Examination of the crystal structures of (Me<sub>4</sub>N)(dcnm) (<b>1</b>), (Me<sub>4</sub>N)(dcn...
Single crystal X-ray structure determinations have previously been described for picrate salts of a ...
Two mixed crystals were obtained by crystallizing the active pharmaceutical ingredient pyridoxine [s...